Thyroid Eye Disease: Pathogenesis and Treatment

被引：7

作者：

Sikder, Shameema ^{[1
]}

Weinberg, Robert S. ^{[2
]}

机构：

[1] Johns Hopkins Univ, Wilmer Eye Inst, Johns Hopkins Hosp, Sch Med,John Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA

[2] Johns Hopkins Bayview, Wilmer Eye Inst, Baltimore, MD USA

来源：

OPHTHALMOLOGICA | 2010年 / 224卷 / 04期

关键词：

Thyroid eye disease; Graves' ophthalmopathy; Graves' disease; GRAVES OPHTHALMOPATHY; MANAGEMENT; RECEPTOR; CLASSIFICATION; EXPRESSION; RITUXIMAB; DEPLETION; TISSUES;

D O I：

10.1159/000260224

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Thyroid eye disease is common, yet poorly understood. Clarification of the pathogenesis of thyroid eye disease should provide a rational therapeutic approach. This article provides a review of current pathogenic theories for the condition and of the medical management based on those theories. Copyright (C) 2009 S. Karger AG, Basel

引用

页码：199 / 203

页数：5

共 50 条

[21] Medical treatment in thyroid eye disease in 2020
Khong, Jwu Jin
McNab, Alan
BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (03) : 299 - 305
[22] Teprotumumab for the treatment of chronic thyroid eye disease
Shoaib Ugradar
Julia Kang
Andrea L. Kossler
Erin Zimmerman
Jenna Braun
Andrew R. Harrison
Swaraj Bose
Kimberly Cockerham
Raymond S. Douglas
Eye, 2022, 36 : 1553 - 1559
[23] Somatostatin analogues in the treatment of thyroid eye disease
Krassas, GE
THYROID, 1998, 8 (05) : 443 - 445
[24] A New Era in the Treatment of Thyroid Eye Disease
Patel, Amy
Yang, Huasheng
Douglas, Raymond S.
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 208 : 281 - 288
[25] THYROID EYE DISEASE - MORE TREATMENT OPTIONS
HARNETT, AN
MACDONALD, A
DUTTON, GN
BRITISH MEDICAL JOURNAL, 1993, 306 (6886): : 1195 - 1195
[26] Rituximab in the Treatment of Thyroid Eye Disease: A Review
Ostrowski, Rochella A.
Bussey, Melissa R.
Shayesteh, Yasmin
Jay, Walter M.
NEURO-OPHTHALMOLOGY, 2015, 39 (03) : 109 - 115
[27] Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease
Men, Clara J.
Amarikwa, Linus
Pham, Brandon
Sears, Connie
Clauss, Kevin
Lee, Bradford W.
Lee, Wendy W.
Pasol, Joshua
Ugradar, Shoaib
Shinder, Roman
Cockerham, Kimberly
Wester, Sara
Douglas, Raymond
Kossler, Andrea L.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (03): : 276 - 285
[28] Teprotumumab for the treatment of chronic thyroid eye disease
Ugradar, Shoaib
Kang, Julia
Kossler, Andrea L.
Zimmerman, Erin
Braun, Jenna
Harrison, Andrew R.
Bose, Swaraj
Cockerham, Kimberly
Douglas, Raymond S.
EYE, 2022, 36 (08) : 1553 - 1559
[29] Lipid metabolites in the pathogenesis and treatment of neovascular eye disease
Stahl, Andreas
Krohne, Tim U.
Sapieha, Przemyslaw
Chen, Jing
Hellstrom, Ann
Chew, Emily
Holz, Frank G.
Smith, Lois E. H.
BRITISH JOURNAL OF OPHTHALMOLOGY, 2011, 95 (11) : 1496 - 1501
[30] Treatment of Hyperthyroidism in Graves' Disease Complicated by Thyroid Eye Disease
Bartalena, Luigi
Smith, Terry J.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025, 110 (04): : 922 - 930

← 1 2 3 4 5 →